<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">21633713</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>09</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-0535</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <PubDate>
                        <Year>2011</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular vision</Title>
                <ISOAbbreviation>Mol. Vis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1275-86</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Retinal ischemia/reperfusion (I/R) injury plays an important role in the pathophysiology of various ocular diseases. Retinal ganglion cells (RGCs) are particularly vulnerable to ischemia. Hydrogen sulfide (H(2)S) was recently shown to be neuroprotective in the brain and retina due to its antiapoptotic effects. Rapid preconditioning of retinal neurons by inhaled H(2)S before I/R injury may reduce apoptosis in the rat retina.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">I/R injury was created on the left eye of rats (n=8) with or without inhaled H(2)S preconditioning (80 ppm) for one hour before ischemia. Densities of fluorogold prelabeled RGCs were analyzed 7 days after injury in retinal whole mounts. Retinal tissue was harvested to analyze protein expression of heat shock protein (HSP)-90 and the mitogen-activated protein kinases (MAPKs) c-jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK)1/2 and p38 to elucidate a possible pathway of neuroprotection. DNA binding activity of the transcription factors nuclear factor-kappa-light-chain-enhancer of activated B-cells (NF-κB), cyclic adenosine monophosphate response element binding protein (CREB), and heat shock element (HSE), as well as caspase-3 cleavage and activity, were determined. Retinal sections were further assessed using anti-glial fibrillary acidic protein staining.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">RGC death after I/R injury decreased by 41.5% after H(2)S preconditioning compared to room air (p&lt;0.001). H(2)S inhalation before ischemia reduced caspase-3 cleavage (p&lt;0.001) and attenuated caspase-3 activity (p&lt;0.001). Furthermore, HSP-90 expression was significantly elevated in the retina after H(2)S preconditioning. NF-κB but not CREB or HSE showed specific, H2S-dependent regulation, as well as the MAPKs ERK1/2 and JNK but not p38.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">H(2)S preconditioning mediates antiapoptotic effects in retinal I/R injury, thus exhibiting neuroprotection. Based on these observations, H(2)S could represent a novel and promising therapeutic agent to counteract neuronal injuries in the eye. Further studies are needed to prove H(2)S's neuroprotective propensity using a postconditioning approach.</AbstractText>
                <CopyrightInformation>© 2011 Molecular Vision</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Biermann</LastName>
                    <ForeName>Julia</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>University Eye Hospital Freiburg, Freiburg, Germany. julia.biermann@uniklinik-freiburg.de</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lagrèze</LastName>
                    <ForeName>Wolf A</ForeName>
                    <Initials>WA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schallner</LastName>
                    <ForeName>Nils</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schwer</LastName>
                    <ForeName>Christian I</ForeName>
                    <Initials>CI</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goebel</LastName>
                    <ForeName>Ulrich</ForeName>
                    <Initials>U</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2011</Year>
                <Month>05</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Vis</MedlineTA>
            <NlmUniqueID>9605351</NlmUniqueID>
            <ISSNLinking>1090-0535</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D061945">Caspase Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D005904">Glial Fibrillary Acidic Protein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018841">HSP90 Heat-Shock Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>9007-49-2</RegistryNumber>
                <NameOfSubstance UI="D004247">DNA</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.24</RegistryNumber>
                <NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>YY9FVM7NSN</RegistryNumber>
                <NameOfSubstance UI="D006862">Hydrogen Sulfide</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061945" MajorTopicYN="N">Caspase Inhibitors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005904" MajorTopicYN="N">Glial Fibrillary Acidic Protein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018841" MajorTopicYN="N">HSP90 Heat-Shock Proteins</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006862" MajorTopicYN="N">Hydrogen Sulfide</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019194" MajorTopicYN="N">Ischemic Preconditioning</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015427" MajorTopicYN="N">Reperfusion Injury</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012160" MajorTopicYN="N">Retina</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012165" MajorTopicYN="N">Retinal Ganglion Cells</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012171" MajorTopicYN="N">Retinal Vessels</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2010</Year>
                <Month>10</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2011</Year>
                <Month>05</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>6</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>6</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>9</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21633713</ArticleId>
            <ArticleId IdType="pmc">PMC3103742</ArticleId>
            <ArticleId IdType="pii">143</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Cereb Blood Flow Metab. 2002 Nov;22(11):1283-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12439285</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2002 Sep;43(9):3059-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12202530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stroke. 2003 May;34(5):1299-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12677017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2004 Jan 9;313(2):362-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14684169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Yan Ke Za Zhi. 2003 Sep;39(9):560-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14766089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Eye Res. 2004 Mar;78(3):723-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15106952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FASEB J. 2004 Jul;18(10):1165-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15155563</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Doc Ophthalmol. 1976 Mar 31;40(2):339-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">817878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Ophthalmol. 1978 Sep;1(1):9-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">553046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 1986 Nov;74(5):1124-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3769170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 1988 Jan;8(1):265-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2448429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Anal Toxicol. 1989 Mar-Apr;13(2):105-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2733387</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 1990 Sep 24;528(1):21-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2245337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Pharmacol Toxicol. 1992;32:109-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1605565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurobiol. 1993 Apr;24(4):528-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8515255</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Hypotheses. 1993 Sep;41(3):205-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7505046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Glaucoma. 1996 Oct;5(5):345-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8897235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cereb Blood Flow Metab. 1997 Feb;17(2):175-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9040497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Shock. 2007 Apr;27(4):370-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17414418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Neurobiol. 2007 Apr;67(5):603-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17443811</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Leukoc Biol. 2007 May;81(5):1322-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17289797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS J. 2007 Jul;274(13):3210-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17565598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pflugers Arch. 2008 Jan;455(4):607-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17674030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can J Physiol Pharmacol. 2007 Dec;85(12):1248-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18066126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurochem Int. 2008 Jan;52(1-2):155-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17629356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Cell Physiol. 2008 Jan;294(1):C169-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17989210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1056-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18326730</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H801-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18567706</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Pharmacol. 2009 Jan;75(1):27-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18832435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmunol. 2009 Jan 3;206(1-2):91-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19028400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Free Radic Biol Med. 2009 Mar 1;46(5):672-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19121385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Shock. 2009 Mar;31(3):267-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18636044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Glia. 2009 Aug 15;57(11):1227-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19170180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Neurosci. 2009 Jul;30(2):175-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19614983</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Biol Int. 2009 Oct;33(10):1095-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19616639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Eye Res. 2009 Nov;89(5):782-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19631642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cardiovasc Pharmacol. 2009 Oct;54(4):287-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19620880</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2010 Jan;51(1):526-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19628741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2010 Jan;51(1):284-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19710416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurochem Int. 2010 Jan;56(1):3-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19703504</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3943-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11053298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 2010 May 5;167(2):277-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20149843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3784-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20181836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 1999 Mar;40(3):713-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10067975</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cereb Blood Flow Metab. 1999 Jul;19(7):757-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10413030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2004 Nov;56(5):611-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15470752</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmologe. 2004 Nov;101(11):1071-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15490183</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Eye Res. 2004 Jun;28(6):381-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15512945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FASEB J. 2004 Nov;18(14):1782-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15371330</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2005 Apr 22;308(5721):518</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15845845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antioxid Redox Signal. 2005 May-Jun;7(5-6):795-803</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15890027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stroke. 2006 Mar;37(3):889-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16439695</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Free Radic Biol Med. 2006 Jul 1;41(1):106-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16781459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 2007 Feb;100(4):1121-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17212697</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1735-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17389506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2001 Nov 1;20(21):6008-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11689441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2002 May 1;22(9):3386-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11978815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1299-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12601062</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>